Dyrenium (Carilion Materials Management)


Welcome to the PulseAid listing for the Dyrenium drug offered from Carilion Materials Management. This Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: Triamterene
SUBSTANCE NAME: TRIAMTERENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1999-10-01
END MARKETING DATE: 0000-00-00


Dyrenium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDyrenium from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 1999-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-1494_fbaaeae0-0b49-4982-bb6d-d9ca44a8f24a
PRODUCT NDC: 68151-1494
APPLICATION NUMBER: NDA013174

Other TRIAMTERENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementDyrenium
Concordia Pharmaceuticals Inc.Dyrenium
WellSpring Pharmaceutical CorporationDyrenium